Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.59) per share which beat the analyst consensus estimate of $(1.00) by 41 percent. The company reported quarterly sales of $3.60 million which missed the analyst consensus estimate of $3.98 million by 9.55 percent. This is a 31.82 percent increase over sales of $2.73 million the same period last year.